Next Article in Journal
Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer
Next Article in Special Issue
Pterostilbene Sensitizes Cisplatin-Resistant Human Bladder Cancer Cells with Oncogenic HRAS
Previous Article in Journal
Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas
Previous Article in Special Issue
CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage
 
 
Article

Article Versions Notes

Cancers 2020, 12(5), 1316; https://doi.org/10.3390/cancers12051316
Action Date Notes Link
article xml file uploaded 21 May 2020 17:04 CEST Original file -
article pdf uploaded. 21 May 2020 17:04 CEST Version of Record https://www.mdpi.com/2072-6694/12/5/1316/pdf-vor
article xml file uploaded 28 May 2020 08:13 CEST Update -
article xml uploaded. 28 May 2020 08:13 CEST Update -
article pdf uploaded. 28 May 2020 08:13 CEST Updated version of record https://www.mdpi.com/2072-6694/12/5/1316/pdf-vor
article html file updated 28 May 2020 08:15 CEST Original file -
article xml file uploaded 28 May 2020 10:17 CEST Update -
article xml uploaded. 28 May 2020 10:17 CEST Update https://www.mdpi.com/2072-6694/12/5/1316/xml
article pdf uploaded. 28 May 2020 10:17 CEST Updated version of record https://www.mdpi.com/2072-6694/12/5/1316/pdf
article html file updated 28 May 2020 10:21 CEST Update -
article html file updated 5 June 2020 18:49 CEST Update -
article html file updated 21 July 2022 05:38 CEST Update https://www.mdpi.com/2072-6694/12/5/1316/html
Back to TopTop